167 related articles for article (PubMed ID: 34607006)
1. Tetraethylthiuram disulphide alleviates pulmonary fibrosis through modulating transforming growth factor-β signalling.
Jiang H; Zhao Y; Tang H; Duan S; Li M; Yang X; Liu J; Lou X; Cai Y; Zhao W; Sun L; Qian F
Pharmacol Res; 2021 Dec; 174():105923. PubMed ID: 34607006
[TBL] [Abstract][Full Text] [Related]
2. Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β.
Li X; Yu H; Liang L; Bi Z; Wang Y; Gao S; Wang M; Li H; Miao Y; Deng R; Ma L; Luan J; Li S; Liu M; Lin J; Zhou H; Yang C
Biochem Pharmacol; 2020 Aug; 178():114097. PubMed ID: 32535102
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
4. P120-catenin regulates pulmonary fibrosis and TGF-β induced lung fibroblast differentiation.
Zhang Y; Jiao H; Wu Y; Sun X
Life Sci; 2019 Aug; 230():35-44. PubMed ID: 31125560
[TBL] [Abstract][Full Text] [Related]
5. Investigating rutin as a potential transforming growth factor-β type I receptor antagonist for the inhibition of bleomycin-induced lung fibrosis.
Karunarathne WAHM; Lee KT; Choi YH; Kang CH; Lee MH; Kim SH; Kim GY
Biofactors; 2024; 50(3):477-492. PubMed ID: 38006284
[TBL] [Abstract][Full Text] [Related]
6. RS4651 suppresses lung fibroblast activation via the TGF-β1/SMAD signalling pathway.
Li S; Xu A; Li Y; Tan C; La Regina G; Silvestri R; Wang H; Qi W
Eur J Pharmacol; 2021 Jul; 903():174135. PubMed ID: 33940030
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
8. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
[TBL] [Abstract][Full Text] [Related]
9. Neohesperidin inhibits TGF-β1/Smad3 signaling and alleviates bleomycin-induced pulmonary fibrosis in mice.
Guo J; Fang Y; Jiang F; Li L; Zhou H; Xu X; Ning W
Eur J Pharmacol; 2019 Dec; 864():172712. PubMed ID: 31586469
[TBL] [Abstract][Full Text] [Related]
10. Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway.
Li A; Xiao X; Feng ZL; Chen X; Liu LJ; Lin LG; Lu JJ; Zhang LL
Toxicol Appl Pharmacol; 2020 Jan; 389():114882. PubMed ID: 31953203
[TBL] [Abstract][Full Text] [Related]
11. Endogenous tryptophan metabolite 5-Methoxytryptophan inhibits pulmonary fibrosis by downregulating the TGF-β/SMAD3 and PI3K/AKT signaling pathway.
Fang L; Chen H; Kong R; Que J
Life Sci; 2020 Nov; 260():118399. PubMed ID: 32918977
[TBL] [Abstract][Full Text] [Related]
12. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
[TBL] [Abstract][Full Text] [Related]
13. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
[TBL] [Abstract][Full Text] [Related]
14. Derrone Targeting the TGF Type 1 Receptor Kinase Improves Bleomycin-Mediated Pulmonary Fibrosis through Inhibition of Smad Signaling Pathway.
Molagoda IMN; Sanjaya SS; Lee KT; Choi YH; Lee JH; Lee MH; Kang CH; Lee CM; Kim GY
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108428
[TBL] [Abstract][Full Text] [Related]
15. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
16. DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition.
Guo X; Adeyanju O; Sunil C; Mandlem V; Olajuyin A; Huang S; Chen SY; Idell S; Tucker TA; Qian G
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C133-C144. PubMed ID: 35584329
[TBL] [Abstract][Full Text] [Related]
17. GRK2 promotes activation of lung fibroblast cells and contributes to pathogenesis of pulmonary fibrosis through increasing Smad3 expression.
Li Y; Sun Y; Wu N; Ma H
Am J Physiol Cell Physiol; 2022 Jan; 322(1):C63-C72. PubMed ID: 34852209
[TBL] [Abstract][Full Text] [Related]
18. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
Pan R; Zhang Y; Zang B; Tan L; Jin M
J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
[TBL] [Abstract][Full Text] [Related]
19. HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.
Lucarini L; Durante M; Lanzi C; Pini A; Boccalini G; Calosi L; Moroni F; Masini E; Mannaioni G
J Cell Mol Med; 2017 Feb; 21(2):324-335. PubMed ID: 27704718
[TBL] [Abstract][Full Text] [Related]
20. Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation.
Nie Y; Zhang D; Jin Z; Li B; Wang X; Che H; You Y; Qian X; Zhang Y; Zhao P; Chai G
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):575-586. PubMed ID: 30854687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]